The Technical Analyst
Cooper Companies Inc [COO]
Exchange: NYSE Sector: Healthcare Industry: Medical Instruments & Supplies
Cooper Companies Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-1.21% $88.84
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 17 657 mill |
| EPS: | 1.460 |
| P/E: | 60.85 |
| Earnings Date: | May 30, 2024 |
| SharesOutstanding: | 198.76 mill |
| Avg Daily Volume: | 1.124 mill |
| RATING 2024-04-26 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Neutral | |
| Return On Asset: | Buy | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 3.94x |
| Company: PE 60.85 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.43x |
| Company: PE 60.85 | industry: PE 42.42 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$38.35 (-56.83%) $-50.49 |
| Date: 2024-04-27 |
| Expected Trading Range (DAY) |
|---|
|
$ 87.12 - 90.56 ( +/- 1.93%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-01 | Weiss Robert S | Buy | 3 180 | Common Stock |
| 2024-04-01 | Weiss Robert S | Buy | 2 993 | Restricted Stock Units |
| 2024-04-01 | Weiss Robert S | Sell | 3 180 | Restricted Stock Units |
| 2024-04-01 | Rivas Maria | Buy | 2 892 | Common Stock |
| 2024-04-01 | Rivas Maria | Buy | 2 721 | Restricted Stock Units |
| INSIDER POWER |
|---|
| -19.89 |
| Last 100 transactions |
| Buy: 400 773 | Sell: 603 371 |
Forecast:
16:00 - $88.86
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $88.86
Forecast 2: 16:00 - $88.86
Forecast 3: 16:00 - $88.86
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $88.84 (-1.21% ) |
| Volume | 1.050 mill |
| Avg. Vol. | 1.124 mill |
| % of Avg. Vol | 93.38 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For COO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $373.43 | N/A | Active |
|---|
COO
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Latest Press Releases
2024-02-29 16:15:00 - Press Release
Coopercompanies Announces First Quarter 2024 Results
San ramon, calif., feb. 29, 2024 (globe newswire) -- coopercompanies (nasdaq: coo), a leading global medical device company, today announced financial results for its fiscal first quarter ended january 31, 2024.
2024-02-15 16:15:00 - Press Release
Coopercompanies 4-for-1 Stock Split Effective Friday (2/16)
San ramon, calif., feb. 15, 2024 (globe newswire) -- coopercompanies (nasdaq: coo) today announced that its four-for-one stock split will become effective on friday, february 16, 2024, at 5:00 pm et, and trading is expected to begin on a stock split-adjusted basis at market open on tuesday, february 20, 2024, under the existing trading symbol “coo”. the stock split supports cooper's desire to make ownership of its stock more accessible to employees and investors.
2024-02-09 08:31:00 - Press Release
Cord Blood Registry® (cbr®) By Coopersurgical® And Fulgent Genetics Launch Innovative Genetic Testing
Testing offers cbr families the opportunity to proactively seek additional information about their child's health trumbull, conn. and el monte, calif.
2024-01-25 16:15:00 - Press Release
Coopercompanies Announces Release Date For First Quarter 2024
San ramon, calif., jan. 25, 2024 (globe newswire) -- coopercompanies (nasdaq: coo) today announced it will report first quarter 2024 financial results on thursday, february 29, 2024, at 4:15 pm et. following the release, the company will host a conference call at 5:00 pm et to discuss the results and current corporate developments.
2023-12-21 16:15:00 - Press Release
Coopercompanies To Present At The J.p. Morgan Healthcare Conference
San ramon, calif., dec. 21, 2023 (globe newswire) -- coopercompanies (nasdaq: coo), a leading global medical device company, will participate at the j.p. morgan healthcare conference on tuesday, january 9, 2024. al white, president and ceo, will represent the company in a session scheduled to begin at 6:00 pm et.
Latest News
2024-04-24 13:01:17 - Zacks Investment Research
The Cooper Companies (COO) Upgraded to Buy: What Does It Mean for the Stock?
The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2024-04-17 12:41:23 - Zacks Investment Research
LH vs. COO: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and The Cooper Companies (COO). But which of these two stocks presents investors with the better value opportunity right now?
2024-04-12 10:26:11 - Zacks Investment Research
Reasons to Hold The Cooper Companies (COO) in Your Portfolio Now
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line.
2024-03-21 23:00:10 - Seeking Alpha
The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
The Cooper Companies stock saw a sharp reversion in share price, leading to a buy rating with an expected 8% return over 6 months. COO's recent results showed 8% growth in constant currency, beating revenue estimates, and raising guidance for FY24. COO is well-positioned to continue delivering growth above the market, with strong product fit and distribution capabilities, and potential for expansion in the myopia management segment.
2024-03-12 12:41:11 - Zacks Investment Research
LH or COO: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Dental Supplies stocks are likely familiar with Labcorp (LH) and The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now?
2024-03-11 09:31:16 - Zacks Investment Research
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line.
2024-03-01 21:59:22 - Seeking Alpha
The Cooper Companies, Inc. (COO) Q1 20243 Earnings Call Transcript
2024-03-01 08:11:07 - Zacks Investment Research
Cooper Companies (COO) Q1 Earnings Top, '24 Outlook Raised
Cooper Companies' (COO) first-quarter fiscal 2024 revenues reflect a solid segmental performance with improved adjusted earnings amid rising expenses.
2024-02-29 19:01:24 - Zacks Investment Research
The Cooper Companies (COO) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended January 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
2024-02-29 18:31:04 - Zacks Investment Research
The Cooper Companies (COO) Q1 Earnings and Revenues Top Estimates
The Cooper Companies (COO) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.73 per share a year ago.